United States Market Monthly Performance for March 2025

Monthly Gainers
1,511
Monthly Losers
4,452
Average Return
-4.38%
Total Stocks
6,167
View Detailed Market Cap Breakdown
Market CapMonthly GainersMonthly LosersAverage ReturnTotal Stocks
Mega Cap 14 33 -4.45% 47
Large Cap 224 499 -3.35% 723
Mid Cap 235 746 -5.41% 986
Small Cap 115 389 -6.61% 508

Monthly Streak Leaders for March 2025

Stock Streak Streak Return
3 months โ†‘ 30.81%

Philip Morris shows promise with a 3-month winning streak (121.34 โ†’ 158.73), delivering 30.8% gains. The financials tell a compelling story: 9.3B revenue generating 2.8B net profit (30.5% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025. This mega-cap's 30.5% net margin reflects operational maturity and pricing power.

3 months โ†‘ 23.87%

AT&T gains traction with a 3-month winning streak (22.83 โ†’ 28.28), delivering 23.9% gains. The financials tell a compelling story: 30.6B revenue generating 4.7B net profit (15.3% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025. For a mega-cap, this sustained momentum signals institutional confidence and market leadership.

4 months โ†“ -10.95%

Microsoft consolidates with a 4-month decline (421.57 โ†’ 375.39), down 11.0%. However, fundamentals remain robust: 69.6B revenue generating 24.1B profit (34.6% margin) as of Qtr ending Dec 2024 suggests this could be a temporary setback. Value hunters take note. Even with 34.6% margins, mega-caps face valuation resets when growth slows.

3 months โ†“ -29.10%

Broadcom consolidates with a 3-month decline (236.16 โ†’ 167.43), down 29.1%. However, fundamentals remain robust: 15.0B revenue generating 5.0B profit (33.1% margin) as of Qtr ending Apr 2025 suggests this could be a temporary setback. Value hunters take note. Even with 33.1% margins, mega-caps face valuation resets when growth slows.

9 months โ†‘ 62.20%

Primo Brands maintains strong momentum with a 9-month winning streak (21.88 โ†’ 35.49), delivering 62.2% gains. With 1.6B revenue generating only 28.7M profit (1.8% margin) in Qtr ending Mar 2025, the market prices in future margin expansion potential. Large-cap resilience shines as market rewards turnaround potential over current metrics.

7 months โ†‘ 5.55%

Rithm Capital shows consistent strength with a 7-month winning streak (23.80 โ†’ 25.12), delivering 5.5% gains. With 493.0M revenue generating only 80.7M profit (16.4% margin) in Qtr ending Mar 2025, the market prices in future margin expansion potential. Large-cap resilience shines as market rewards turnaround potential over current metrics.

9 months โ†“ -40.87%

Biogen faces persistent headwinds with a 9-month decline (231.41 โ†’ 136.84), down 40.9%. Weak margins on 2.4B revenue with only 240.5M profit (9.9% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before sentiment shifts. Large-cap declines test whether scale advantages offset margin pressures.

7 months โ†“ -24.10%

Merck & Co navigates difficult waters with a 7-month decline (118.26 โ†’ 89.76), down 24.1%. However, fundamentals remain robust: 15.5B revenue generating 5.1B profit (32.7% margin) as of Qtr ending Mar 2025 suggests this could be a temporary setback. Value hunters take note. Despite solid 32.7% margins, large-caps aren't immune to sentiment shifts.

8 months โ†‘ 80.82%

Paycor HCM maintains strong momentum with a 8-month winning streak (12.41 โ†’ 22.44), delivering 80.8% gains. Despite 180.4M in revenue and - 2.0M loss (-1.1% margin) as of Qtr ending Dec 2024, the market sees potential beyond current profitability. This momentum suggests confidence in future execution. Mid-cap agility allows pivoting strategies as market dynamics evolve.

8 months โ†‘ 57.66%

SolarWinds maintains strong momentum with a 8-month winning streak (11.69 โ†’ 18.43), delivering 57.7% gains. The financials tell a compelling story: 210.3M revenue generating 72.7M net profit (34.6% margin) demonstrates exceptional profit margins as of Qtr ending Dec 2024. This mid-cap's 34.6% profit margin signals transition to profitable scale.

9 months โ†“ -65.07%

Axcelis experiences extended pressure with a 9-month decline (142.19 โ†’ 49.67), down 65.1%. However, fundamentals remain robust: 192.6M revenue generating 28.6M profit (14.8% margin) as of Qtr ending Mar 2025 suggests this could be a temporary setback. Value hunters take note. Mid-cap volatility despite strong fundamentals creates value opportunities.

8 months โ†“ -71.53%

Moderna struggles to find footing after a 8-month decline (99.58 โ†’ 28.35), down 71.5%. Financial struggles compound the decline: despite 107.0M revenue, - 971.0M losses persist (-907.5% margin) as of Qtr ending Mar 2025. Until profitability improves, caution remains warranted. Mid-cap flexibility becomes crucial when growth stalls and margins compress.

6 months โ†‘ 39.12%

Air Transport builds on success with a 6-month winning streak (16.13 โ†’ 22.44), delivering 39.1% gains. With 516.8M revenue generating only 14.7M profit (2.8% margin) in Qtr ending Dec 2024, the market prices in future margin expansion potential. Small-cap volatility rewards believers as fundamentals catch up to valuation.

5 months โ†‘ 142.75%

Paragon starts to shine with a 5-month winning streak (5.38 โ†’ 13.06), delivering 142.8% gains. Despite 71.7M in revenue and - 11.1M loss (-15.5% margin) as of Qtr ending Dec 2024, the market sees potential beyond current profitability. This momentum suggests confidence in future execution. Early-stage losses typical for growth-focused small-caps prioritizing market share.

10 months โ†“ -44.01%

Blue Bird experiences extended pressure with a 10-month decline (57.81 โ†’ 32.37), down 44.0%. Revenue of 358.9M provides a foundation, but 26.0M net income (7.3% margin) in Qtr ending Mar 2025 highlights operational challenges that need addressing. Small-cap risk-off sentiment amplifies declines regardless of operational progress.

9 months โ†“ -57.04%

Veeco Instruments faces persistent headwinds with a 9-month decline (46.74 โ†’ 20.08), down 57.0%. Weak margins on 167.3M revenue with only 11.9M profit (7.1% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before sentiment shifts. Thin margins leave little room for error in unforgiving small-cap markets.

United States Market Monthly Gainers & Losers: March 2025

Top United States Stock Gainers (March 2025)

StockMonth OpenMonth CloseMonthly ChangeAvg Daily VolumeMonth Volume
$474.37 $523.75 10.27% 4.23M 93.13M
$68.42 $73.28 8.63% 5.59M 123.00M
$111.70 $118.93 6.83% 17.53M 385.65M
$159.46 $167.29 5.47% 9.03M 198.73M
$516.22 $532.58 3.65% 4.92M 108.21M
$4.60 $31.88 593.04% 1.81M 39.92M
$26.20 $35.62 38.65% 9.07M 199.62M
$333.99 $383.68 23.37% 103.88K 2.29M
$86.35 $100.64 18.61% 3.50K 77.00K
$73.57 $87.93 18.54% 4.48M 98.47M
$61.39 $114.22 88.54% 1.64M 36.12M
$48.93 $71.45 46.35% 1.74M 38.24M
$4.48 $6.10 41.20% 15.68M 345.06M
$5.58 $7.60 38.69% 82.95M 1.82B
$2.75 $3.71 36.40% 20.84M 458.38M
$3.62 $7.00 95.53% 1.32M 29.02M
$11.30 $18.77 68.79% 2.14M 46.98M
$15.77 $23.35 49.30% 1.42M 31.24M
$3.63 $5.22 43.01% 773.68K 17.02M
$6.61 $9.21 38.08% 12.35M 271.68M

Biggest United States Stock Losers (March 2025)

StockMonth OpenMonth CloseMonthly ChangeAvg Daily VolumeMonth Volume
$204.00 $167.43 -16.05% 34.18M 751.94M
$166.95 $139.81 -15.81% 11.78M 259.19M
$936.01 $796.14 -14.37% 2.05M 44.99M
$673.68 $576.36 -13.74% 16.52M 363.41M
$114.07 $98.70 -13.27% 9.51M 209.17M
$165.46 $104.90 -35.16% 9.15M 201.33M
$32.81 $21.11 -35.03% 13.00M 285.97M
$44.97 $29.55 -34.46% 21.43M 471.44M
$270.63 $175.40 -34.41% 3.10M 68.16M
$91.99 $61.57 -32.94% 19.64M 432.10M
$73.17 $37.76 -48.29% 1.64M 36.16M
$16.24 $8.82 -45.12% 1.69M 37.17M
$14.64 $8.29 -40.66% 2.01M 44.27M
$24.77 $15.52 -37.75% 10.31M 226.79M
$34.75 $21.63 -35.22% 12.34M 271.40M
$1.50 $1.50 -86.36% 5 100
$0.70 $0.31 -53.73% 650.84K 14.32M
$14.81 $7.45 -48.90% 16.52M 363.33M
$5.49 $2.86 -44.57% 41.50M 913.08M
$4.51 $2.30 -43.63% 12.48M 274.49M

Most Active United States Stocks During March 2025

StockMonth OpenMonth CloseMonthly ChangeAvg Daily VolumeMonthly Volume
$123.51 $108.38 -13.24% 280.82M 6.18B
$9.71 $10.03 5.03% 136.88M 3.01B
$300.34 $259.16 -11.54% 123.59M 2.72B
$88.55 $84.40 -0.61% 100.28M 2.21B
$25.00 $22.71 -4.30% 100.22M 2.20B
$2.27 $2.42 9.01% 92.40M 2.03B
$5.58 $7.60 38.69% 82.95M 1.82B
$4.49 $3.81 -17.71% 66.97M 1.47B
$42.28 $34.24 -17.41% 63.31M 1.39B
$14.36 $10.55 -26.48% 62.25M 1.37B
$1.61 $1.35 -16.15% 60.83M 1.34B
$1.53 $1.30 -12.75% 59.92M 1.32B
$11.00 $10.24 -4.74% 57.29M 1.26B
$8.54 $7.92 -6.38% 55.79M 1.23B
$26.37 $25.34 -4.12% 55.08M 1.21B
$241.79 $222.13 -8.15% 50.69M 1.12B
$2.26 $2.23 -1.33% 45.94M 1.01B
$27.27 $28.28 3.17% 44.49M 978.85M
$5.49 $2.86 -44.57% 41.50M 913.08M
$4.31 $2.73 -34.84% 32.68M 718.97M

United States Sector Performance During March 2025

Consumer Defensive

11.33%
244 stocks
Top Performers by Market Cap:
Mega Cap: PM +2.22%
Large Cap: CELH +38.65%
Small Cap: YSG +26.25%

Industrials

5.15%
695 stocks
Top Performers by Market Cap:
Mega Cap: GE -3.30%
Large Cap: ESLT +23.37%
Mid Cap: WOR +19.29%
Small Cap: ATRO +20.79%

Basic Materials

1.84%
264 stocks
Top Performers by Market Cap:
Mega Cap: LIN -0.30%
Large Cap: KGC +17.63%
Mid Cap: FSM +41.20%
Small Cap: ARMN +25.41%

Real Estate

-0.16%
270 stocks
Top Performers by Market Cap:
Large Cap: CCI +10.77%
Mid Cap: MRP +15.97%
Small Cap: RDFN +38.08%

Utilities

-2.32%
98 stocks
Top Performers by Market Cap:
Large Cap: ED +8.93%
Small Cap: MSEX +27.87%

Financial Services

-3.04%
1048 stocks
Top Performers by Market Cap:
Mega Cap: BRK.B +3.65%
Large Cap: WRB +12.81%
Small Cap: PRA +49.30%

Energy

-3.63%
216 stocks
Top Performers by Market Cap:
Mega Cap: SHEL +8.63%
Large Cap: EXEEL +18.61%
Mid Cap: VRN +21.47%
Small Cap: LPG +9.72%

Communication Services

-4.55%
260 stocks
Top Performers by Market Cap:
Mega Cap: T +3.17%
Large Cap: EA +11.93%
Mid Cap: BZ +19.81%
Small Cap: GRPN +68.79%

Technology

-9.41%
805 stocks
Top Performers by Market Cap:
Mega Cap: AMD +2.88%
Large Cap: OKTA +16.28%
Small Cap: AEVA +95.53%

Consumer Cyclical

-9.96%
591 stocks
Top Performers by Market Cap:
Mega Cap: MCD +1.31%
Large Cap: AZO +9.15%
Mid Cap: SIG +10.97%
Small Cap: TRS +14.35%

Healthcare

-11.20%
1212 stocks
Top Performers by Market Cap:
Mega Cap: UNH +10.27%
Large Cap: RGC +593.04%
Small Cap: ASTH +22.18%

Data is updated regularly. Monthly performance is calculated based on closing prices.